uniQure
QURE
#5575
Rank
A$2.02 B
Marketcap
A$28.80
Share price
-5.09%
Change (1 day)
-33.12%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2026 (TTM): -A$0.34 Billion

According to uniQure's latest financial reports the company's current earnings are A$20.16 Million. In 2025 the company made an earning of -A$0.3 Billion, an increase over its 2024 earnings that were of -A$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.34 Billion17.1%
2025 -A$0.3 Billion-18.47%
2024 -A$0.36 Billion-22.65%
2023 -A$0.46 Billion139.01%
2022 -A$0.2 Billion-138.54%
2021 A$0.49 B-335.29%
2020 -A$0.22 Billion13.88%
2019 -A$0.19 Billion49.51%
2018 -A$0.13 Billion4.55%
2017 -A$0.12 Billion12.65%
2016 -A$0.11 Billion-9.59%
2015 -A$0.12 Billion66.95%
2014 -A$70.11 Million30.8%
2013 -A$53.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$16.57 B-4,826.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.68 B-3,430.95%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-A$0.17 Billion-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-A$0.3 Billion-14.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$65.5 M-118.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-A$1.03 Billion 192.82%๐Ÿ‡บ๐Ÿ‡ธ USA